Paxmedica Inc (PXMD)

Currency in USD
0.0001
0.0000(0.00%)
Closed·
PXMD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
0.00010.0001
52 wk Range
0.00010.2590
Key Statistics
Prev. Close
0.0001
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-0.259
Volume
-
Average Volume (3m)
5.41K
1-Year Change
-99.96%
Book Value / Share
-0.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PXMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Paxmedica Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Paxmedica Inc Company Profile

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is PAX-101 that is in Phase 3 clinical trials, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, fragile X syndrome, human African trypanosomiasis (HAT), and fragile X-associated tremor/ataxia syndrome. The company is developing PAX-102, an intranasal formulation of suramin for neurologic indications, as well as other new chemical entities that are targeted and selective antagonists of purine receptor subtypes; and PAX-HAT-301 for the treatment of HAT. It has a research collaboration agreement with PolarMar Health for Phase II clinical trial in austism spectrum disorder for emodin, which retains the rights for PolarMar to develop and commercialize any non-prescription supplement form of the product, and for PaxMedica, Inc. to retain exclusive rights to develop and commercialize a highly purified form of emodin. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.

Compare PXMD to Peers and Sector

Metrics to compare
PXMD
Peers
Sector
Relationship
P/E Ratio
0.0x−0.3x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.8x2.6x
Price / LTM Sales
-1.7x3.3x
Upside (Analyst Target)
-173.2%45.1%
Fair Value Upside
Unlock19.7%7.4%Unlock

Earnings

Latest Release
Sep 20, 2024
EPS / Forecast
-0.39 / -0.30
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PXMD Income Statement

FAQ

What Stock Exchange Does Paxmedica Trade On?

Paxmedica is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Paxmedica?

The stock symbol for Paxmedica is "PXMD."

What Is the Paxmedica Market Cap?

As of today, Paxmedica market cap is 12.61K.

What Is Paxmedica's Earnings Per Share (TTM)?

The Paxmedica EPS (TTM) is -3.51.

From a Technical Analysis Perspective, Is PXMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Paxmedica Stock Split?

Paxmedica has split 1 times.

How Many Employees Does Paxmedica Have?

Paxmedica has 7 employees.

What is the current trading status of Paxmedica (PXMD)?

As of 04 Aug 2025, Paxmedica (PXMD) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.26.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.